Cosmetic Supply Chain Transparency Act of 2023
Latest action · May 26, 2023 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 24, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Cosmetic Supply Chain Transparency Act of 2023
This bill requires the Food and Drug Administration (FDA) to maintain a list of certain nonfunctional constituents in cosmetics that are harmful to human health or the environment, authorizes the FDA to request from a brand owner (i.e., the entity bringing a cosmetic to market) certain information about a cosmetic's ingredients, and addresses related issues.
For each listed nonfunctional constituent, the list must identify the ingredient or cosmetic (or category of ingredient or cosmetic) in which the constituent is known or reasonably expected to be present. The FDA must also (1) establish procedures for petitions to add substances to the list, (2) issue guidance for industry related to testing and detecting such nonfunctional constituents, and (3) establish a committee to provide advice on creating the list and developing the required industry guidance.
Within a year of a nonfunctional constituent being added to the list, a supplier of an ingredient or cosmetic must test for that constituent and provide a brand owner the results and other information before selling the ingredient or cosmetic to the brand owner. A supplier of an ingredient or cosmetic must provide additional information about the item upon a brand owner's request.
Brand owners must maintain records with information about the suppliers of ingredients and raw materials used in their cosmetics and provide such information to the FDA upon request.
The bill also imposes civil penalties for brand owners and suppliers that violate this bill's provisions.
Cosponsors 14
Members who signed on, in the order they did. Signatures ran from May 24, 2023 to Oct 18, 2024, with 6 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-DC | Eleanor Holmes Norton | Original | May 24, 2023 |
| D-NY | Grace Meng | Original | May 24, 2023 |
| D-GA | Henry C. "Hank" Johnson, Jr. | Original | May 24, 2023 |
| D-NY | Nydia M. Velázquez | Original | May 24, 2023 |
| D-MI | Rashida Tlaib | Original | May 24, 2023 |
| D-AZ | Raúl M. Grijalva | Original | May 24, 2023 |
| D-FL | Sheila Cherfilus-McCormick | Jun 6, 2023 | |
| D-CA | Zoe Lofgren | Jun 16, 2023 | |
| D-GA | Nikema Williams | May 6, 2024 | |
| D-OH | Shontel M. Brown | May 14, 2024 | |
| D-TX | Sheila Jackson Lee | May 21, 2024 | |
| D-NM | Melanie A. Stansbury | Jun 3, 2024 | |
| D-MI | Debbie Dingell | Sep 17, 2024 | |
| D-CA | Doris O. Matsui | Oct 18, 2024 |
Actions 3
Everything that happened, newest first.
- May 26, 2023Referred to the Subcommittee on Health.
- May 24, 2023Introduced in House
- May 24, 2023Referred to the House Committee on Energy and Commerce.
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Advisory bodies
- Business records
- Civil actions and liability
- Cosmetics and personal care
- Drug safety, medical device, and laboratory regulation
- Food and Drug Administration (FDA)
- Government information and archives
- Hazardous wastes and toxic substances
- Health
- Retail and wholesale trades
Text 1
Each version as it was printed, newest first.
- May 24, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.